Blocking of NF-kB activation by ASX was the main reason explaining its anti-inflammatory effect (19). Significantly, some studies have shown that metformin, which is used for treating type 2 diabetes mellitus (DM), reduces oxidative stress. This evidence concerns the gene NFKB1 and diabetes mellitus.